Litcius/Paper detail

Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model

Alexander Jenke, Julia Kistner, Sarah Saradar, Agunda Chekhoeva, Mariam Yazdanyar, Ann Kathrin Bergmann, Melanie Vera Rötepohl, Artur Lichtenberg, Payam Akhyari

2020American Journal of Physiology-Heart and Circulatory Physiology38 citationsDOI

Abstract

Employing aortic valve leaflets as a tissue-based three-dimensional disease model, our study investigates the role of transforming growth factor (TGF)-β1 in calcific aortic valve disease pathogenesis. We find that, by activating Mothers against decapentaplegic homolog 3, TGF-β1 intensifies expressional and proliferative activation along with myofibroblastic differentiation of valvular interstitial cells, thus triggering dominant fibrosis. Simultaneously, by inhibiting activation of Mothers against decapentaplegic homolog 1/5/8 and canonical Wnt/β-catenin signaling, TGF-β1 attenuates apoptosis and osteoblastic differentiation of valvular interstitial cells, thus blocking valvular tissue calcification. These findings question a general phase-independent calcific aortic valve disease-promoting role of TGF-β1.

Topics & Concepts

CalcificationMedicineFibrosisvalvular heart diseaseCardiologyAortic valveInternal medicineTransforming growth factorCalcinosisDiseaseCardiac Valve Diseases and TreatmentsConnective tissue disorders researchHypertrophic osteoarthropathy and related conditions